EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease

Emmanouil Mavrogeorgis iD, Tianlin He iD, Harald Mischak iD, Agnieszka Latosinska iD, Antonia Vlahou iD, Joost P Schanstra iD, Lorenzo Catanese iD, Kerstin Amann iD, Tobias B Huber iD, Joachim Beige iD, Harald D Rupprecht iD, Justyna Siwy iD

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfad200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Emmanouil Mavrogeorgis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mosaiques Diagnostics GmbH, Hannover, Germany. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Glomerulonephritis, IGA, Vasculitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, German Research Foundation, Federal Ministry of Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis Specific urinary peptides hold information on disease pathophysiology, which, in combination with artificial intelligence, could enable non-invasive assessment of chronic kidney disease (CKD) aetiology. Existing approaches are generally specific for the diagnosis of single aetiologies. We present the development of models able to simultaneously distinguish and spatially visualize multiple CKD aetiologies.

Methods

The urinary peptide data of 1850 healthy control (HC) and CKD [diabetic kidney disease (DKD), immunoglobulin A nephropathy (IgAN) and vasculitis] participants were extracted from the Human Urinary Proteome Database. Uniform manifold approximation and projection (UMAP) coupled to a support vector machine algorithm was used to generate multi-peptide models to perform binary (DKD, HC) and multiclass (DKD, HC, IgAN, vasculitis) classifications. This pipeline was compared with the current state-of-the-art single-aetiology CKD urinary peptide models.

Results

In an independent test set, the developed models achieved 90.35% and 70.13% overall predictive accuracies, respectively, for the binary and the multiclass classifications. Omitting the UMAP step led to improved predictive accuracies (96.14% and 85.06%, respectively). As expected, the HC class was distinguished with the highest accuracy. The different classes displayed a tendency to form distinct clusters in the 3D space based on their disease state.

Conclusion

Urinary peptide data present an effective basis for CKD aetiology differentiation using machine learning models. Although adding the UMAP step to the models did not improve prediction accuracy, it may provide a unique visualization advantage. Additional studies are warranted to further validate the pipeline's clinical potential as well as to expand it to other CKD aetiologies and also other diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicGlomerulonephritis, IGAVasculitisHumansBiomarkersDiagnosis, DifferentialArtificial IntelligenceLiquid BiopsyPeptidesProteomics

Stichwörter der Autor:innen

UMAPchronic kidney diseasedifferential diagnosispeptidesurine

Substanzen

BiomarkersPeptides

Autor:innen und Institutionen

  • Mosaiques Diagnostics GmbH, Hannover, Germany.
  • Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University Hospital, Aachen, Germany.
  • Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, Toulouse, France.
  • Université Toulouse III Paul-Sabatier, Toulouse, France.
  • Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany.

ORCID-Profile: Emmanouil Mavrogeorgis, Tianlin He, Harald Mischak, Agnieszka Latosinska, Antonia Vlahou, Joost P Schanstra, Lorenzo Catanese, Kerstin Amann, Tobias B Huber, Joachim Beige, Harald D Rupprecht, Justyna Siwy

Förderung

  • European Commission
  • German Research Foundation
  • Federal Ministry of Education and Research
  • COST

Zitieren

APA

Mavrogeorgis, E., He, T., Mischak, H., Latosinska, A., Vlahou, A., Schanstra, J. P., Catanese, L., Amann, K., Huber, T. B., Beige, J., Rupprecht, H. D., & Siwy, J. (2024). Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad200

Vancouver

Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, et al. Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad200

BibTeX
@article{Mavrogeorgis2024,
  author = {Mavrogeorgis, Emmanouil and He, Tianlin and Mischak, Harald and Latosinska, Agnieszka and Vlahou, Antonia and Schanstra, Joost P and Catanese, Lorenzo and Amann, Kerstin and Huber, Tobias B and Beige, Joachim and Rupprecht, Harald D and Siwy, Justyna},
  title = {Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad200}
}
Kostenlos starten →